Page 8 - David Coman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Search jobs 07-May-2021 Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future Transaction values Science 37 at an enterprise value of approximately $1.05 billion at closing Positions Science 37 with a balance sheet of up to $250 million to fund its decentralized trial technology platform, extend into new adjacencies, and power the next generation in clinical research $80 million via LifeSci Acquisition II Corp., a special purpose acquisition company with no publ...

Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers Using Science 37's decentralized clinical trial model, the partnership offers Xperiome's research-ready, rare disease patients more study opportunities with less burden. News provided by Share this article Share this article LOS ANGELES, March 11, 2021 /PRNewswire/ -- Science 37, the industry leader in decentralized clinical trials, announced today a partnership with Xperiome, a global rare disease healthtech company. The partnership further strengthens Science 37's ca...

Science 37® and Medgate Partner to Further Globalize Decentralized Clinical Trials With a presence in Europe, Asia-Pacific, and the Middle East, Medgate extends the Science 37 Decentralized Clinical Trial Operating System--enabling more provider and patient research participation. News provided by Share this article Share this article LOS ANGELES, March 2, 2021 /PRNewswire/ -- Science 37, the industry leader in decentralized clinical trials, announced today a strategic partnership with Medgate, a leading international digital health and telemedicine company and operator of Europe's largest t...

Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy.

/PRNewswire/ -- Science 37, the industry leader in decentralized clinical trials, today announced a premier partnership program, Science 37 Certified, designed...